Pharming (PHAR) Enterprise Value (2019 - 2026)
Pharming (PHAR) posted Enterprise Value of -$52.4 million for Q1 2026, up 63.95% on a QoQ basis from -$145.3 million in Q4 2025, and up 10.92% year-over-year from -$47.2 million in Q1 2025.
Pharming (PHAR) Enterprise Value (2019 - 2026) Analysis & Trends
Pharming's Enterprise Value history runs 8 years deep, the most recent figure standing at -$52.4 million for Q1 2026.
- Quarterly Enterprise Value rose 10.92% year-over-year to -$52.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52.4 million (up 10.92% YoY) and the FY2025 annual result came in at -$145.3 million, down 9587.0% from the prior year.
- Enterprise Value was -$52.4 million for Q1 2026 at Pharming, up from -$145.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.5 million in Q4 2024 and bottomed at -$207.3 million in Q4 2022.
- A 5-year average of -$121.6 million and a median of -$132.4 million in 2025 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 99.91% in 2022, while the deepest fall reached 106934.94% in 2022.
- Pharming's Enterprise Value stood at -$207.3 million in 2022, then jumped by 70.22% to -$61.7 million in 2023, then jumped by 97.57% to -$1.5 million in 2024, then tumbled by 9587.0% to -$145.3 million in 2025, then surged by 63.95% to -$52.4 million in 2026.
- Business Quant data shows PHAR's Enterprise Value at -$52.4 million in Q1 2026, -$145.3 million in Q4 2025, and -$132.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | -52.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.38 Mn |
| Dec 31, 2025 | -145.31 Mn |
| Sep 30, 2025 | -132.37 Mn |
| Jun 30, 2025 | -92.09 Mn |
| Mar 31, 2025 | -58.80 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | -60.66 Mn |
| Jun 30, 2024 | -47.14 Mn |
| Mar 31, 2024 | -51.89 Mn |
| Dec 31, 2023 | -61.74 Mn |
| Sep 30, 2023 | -207.34 Mn |
| Jun 30, 2023 | -192.37 Mn |
| Mar 31, 2023 | -184.78 Mn |
| Dec 31, 2022 | -207.34 Mn |
| Sep 30, 2022 | -191.92 Mn |
| Jun 30, 2022 | -189.96 Mn |
| Mar 31, 2022 | -189.67 Mn |
| Dec 31, 2021 | -193,714.32 |
| Sep 30, 2021 | -183.32 Mn |
| Jun 30, 2021 | -188.30 Mn |